- Home
- RNAZ vs SEED Comparison
RNAZ vs SEED Comparison
Compare RNAZ & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- SEED
- Stock Information
- Founded
- RNAZ 2016
- SEED 1997
- Country
- RNAZ United States
- SEED China
- Employees
- RNAZ N/A
- SEED N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- SEED Farming/Seeds/Milling
- Sector
- RNAZ Health Care
- SEED Consumer Staples
- Exchange
- RNAZ Nasdaq
- SEED Nasdaq
- Market Cap
- RNAZ 6.1M
- SEED 6.9M
- IPO Year
- RNAZ 2021
- SEED N/A
- Fundamental
- Price
- RNAZ $11.51
- SEED $0.99
- Analyst Decision
- RNAZ Strong Buy
- SEED
- Analyst Count
- RNAZ 1
- SEED 0
- Target Price
- RNAZ $280.00
- SEED N/A
- AVG Volume (30 Days)
- RNAZ 251.6K
- SEED 77.6K
- Earning Date
- RNAZ 08-22-2025
- SEED 06-26-2025
- Dividend Yield
- RNAZ N/A
- SEED N/A
- EPS Growth
- RNAZ N/A
- SEED N/A
- EPS
- RNAZ N/A
- SEED N/A
- Revenue
- RNAZ N/A
- SEED $12,910,081.00
- Revenue This Year
- RNAZ N/A
- SEED N/A
- Revenue Next Year
- RNAZ N/A
- SEED N/A
- P/E Ratio
- RNAZ N/A
- SEED N/A
- Revenue Growth
- RNAZ N/A
- SEED N/A
- 52 Week Low
- RNAZ $6.15
- SEED $0.74
- 52 Week High
- RNAZ $739.20
- SEED $3.59
- Technical
- Relative Strength Index (RSI)
- RNAZ 56.95
- SEED 47.92
- Support Level
- RNAZ $10.16
- SEED $0.96
- Resistance Level
- RNAZ $12.10
- SEED $1.10
- Average True Range (ATR)
- RNAZ 1.40
- SEED 0.10
- MACD
- RNAZ -0.11
- SEED 0.00
- Stochastic Oscillator
- RNAZ 23.51
- SEED 26.67
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.